EGA Talks Biosimilars

The European Generic Medicines Association's Director for Scientific Affairs, Suzette Cox, talks to us about the environment for biosimilars.

Related Content:

GlobalR&D/Clinical TrialsGlobal

European Commission Approves Tepkinly for Adults With Relapesed or Refractory Diffuse Large B-cell Lymphoma

The Global Vaccine R&D Pipeline and Delivery Implications

The EU Regulations Catching US Pharma Companies Off Guard